Back to top

Moleculin Biotech Highlights Promising MIRACLE Trial Remission Data

Moleculin Biotech ( ($MBRX) ) has shared an announcement. On July 31, 2026, Moleculin reported updated preliminary blinded data from Part A of its ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moleculin Biotech, Inc. (MBRX)